Bioresorbable Vascular Scaffolds Versus Metallic Stents in Patients With Coronary Artery Disease: ABSORB China Trial

The everolimus-eluting bioresorbable vascular scaffold (BVS) is designed to achieve results comparable to metallic drug-eluting stents at 1 year, with improved long-term outcomes. Whether the 1-year clinical and angiographic results of BVS are noninferior to current-generation drug-eluting stents ha...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American College of Cardiology 2015-12, Vol.66 (21), p.2298-2309
Hauptverfasser:	Gao, Runlin, Yang, Yuejin, Han, Yaling, Huo, Yong, Chen, Jiyan, Yu, Bo, Su, Xi, Li, Lang, Kuo, Hai-Chien, Ying, Shih-Wa, Cheong, Wai-Fung, Zhang, Yunlong, Su, Xiaolu, Xu, Bo, Popma, Jeffery J, Stone, Gregg W
Format:	Artikel
Sprache:	eng
Schlagworte:	Absorbable Implants - standards Absorbable Implants - trends Aged China - epidemiology Coronary Artery Disease - diagnostic imaging Coronary Artery Disease - epidemiology Coronary Artery Disease - surgery Drug-Eluting Stents - standards Drug-Eluting Stents - trends Female Follow-Up Studies Humans Male Metals - standards Middle Aged Prospective Studies Radiography Stents - standards Stents - trends Tissue Scaffolds - standards Tissue Scaffolds - trends Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!